Integrated BioSci Investing Launched: Exclusive Intelligence And Consulting From Dr. Tran

Jul. 14, 2017 9:45 AM ETICPT, MDVN, EXEL, IBB, JAZZ2 Comments


  • Integrated BioSci Investing is an exclusive research intelligence and consulting service (delivered from medical and market experts).
  • We simplify the complexity of bioscience investing to assist investors who expect outperformance, in-depth communication, and consulting.
  • Subscription includes once-weekly, high-level research with monthly consults, direct access to the author, and a model portfolio.
  • Current rate is offered to the first 25 subscribers. And, membership will close once there are 1,000 members.

(Editors' Note: This article is meant as an introduction for Integrated BioSci Investing, a new Marketplace service by Dr. Tran BioSci).

For the past decade, the Biotechnology Index (NASDAQ:IBB) enjoyed 297% profits. In contrast, the S&P 500 Value (INDEX:SP500V) and the Dow Jones Industrial Average (INDEX:(DJI)) procured 27% and 58%, respectively. Even more exciting is that a bioscience stock can gain +100% (or tumble +80%) in a trading session due to the outcomes of a binary event (for instance, a clinical trial data report or an FDA approval). Despite its lucrative returns, biotech investing can deter even seasoned investors due to the complexity of science and medicine (as well as medical jargon).

Source: Google Finance

Viewing clients as partners with aligned interests, we launched this marketplace to break down the aforesaid barriers to successful bioscience investing (as well as to deliver an edge in binary events analysis) for you. And, we leverage on our medical and market expertise (in building an exclusive community of investors, who expect outperformance, high-level communication through consulting, and the expert edge).

With the subscription, you’ll receive at least once-weekly Integrated BioSci Research (available exclusive to members). The report is a 6-10 pages in-depth analysis of an investing thesis by employing comprehensive views from multiple perspectives. Moreover, you can get your question answered directly via messaging. Furthermore, there is a live chat feature for you to address your questions (or to share your insight with other members).

To further simplify the intricacies of biopharma investing, we’ve set up an outperforming portfolio that you can mirror (which consists of at least 10 stocks). The figure below is a model outperformance portfolio of notable winners and losers that we conducted since 2013.

Source: Dr. Tran BioSci

Over time, we will add more firms to ensure that you have further

This article was written by

BioSci Capital Partners profile picture
Become an Expert Bio-Investor with the Columbia Doc/Scientist/Market Whiz

Founded by Dr. Harvey Tran MD, MS, CNPR, (in collaboration with other PhDs), Integrated BioSci Investing LLC (“IBI) is a growing community of experts and everyday investors who help one another to invest better.

We bring to you a NEW investment philosophy called “Integrated BioSci Investing.” It's a distillation of value/growth investing wisdom from gurus such as Warren Buffett, Buffet's mentors (Ben Graham and Phil Fischer), and Sir John Templeton that are adapted specifically for biotech stocks.

IBI's analytical research is powered by the integration of (medical, scientific, and market) expertise to deliver unprecedented accuracy in clinical trial forecasting that, in and of itself, is one of the requisites to finding alpha bioscience investment.

Ultimately, our tireless due diligence and the wisdom of IBI members translate into strong returns for you. To name a couple of winners, Crispr Therapeutics (CRSP), CryoPort (CYRX), and Guardant Health (GH), correspondingly delivered 679.1%, 778.3%, and +435.9% for our subscribers."

As an IBI member, you’ll enjoy the following EXCLUSIVE benefits: daily real-time research articles that are comprehensive and more in-depth than free research articles; access to the chat room with many experts and everyday investors for you to ask your questions live about your favorite stocks (you’re expected to get an answer no later than 24 hours); ability to view our high performing portfolios and their pertinent updates; consulting on strategies to help you set up your own portfolios; Our best ideas and their updates via a research article or chat; potential to have research featured on your favorite companies; ability to reach Dr. Tran via phone call or Skype as you wish.

CLICK the orange FOLLOW button to receive the FREE real-time alerts on our articles and blogs.

CONNECT with Dr. Tran through his LinkedTree

READ more on (and make sure to register for our mailing list).

LEARN about Dr. Tran’s background in an in-depth article by following this link.

"Stellar therapeutics for patients. Differentiated intelligence for investors. Premium valuations for firms."

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.